Vaccine-induced V1V2-specific antibodies control and or protect against infection with HIV, SIV and SHIV

PURPOSE OF REVIEW: In humans, only one independent immunologic correlate of reduced risk of HIV infection has been identified: a robust antibody (Ab) response to the V1V2 domain of the gp120 envelope (Env) protein. In recent years, the presence and level of V1V2-specific Abs has also been correlated...

Descripción completa

Detalles Bibliográficos
Autores principales: Zolla-Pazner, Susan, Alvarez, Raymond, Kong, Xiang-Peng, Weiss, Svenja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
BROAD NEUTRALISING AND NON-NEUTRALISING ANTIBODIES: Edited by Hugo Mouquet and Olivier Schwartz
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542703/
https://www.ncbi.nlm.nih.gov/pubmed/30994501
http://dx.doi.org/10.1097/COH.0000000000000551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542703/
https://www.ncbi.nlm.nih.gov/pubmed/30994501
http://dx.doi.org/10.1097/COH.0000000000000551

Ejemplares similares